Moreover, blockade of MDK/ALK signaling enhances the response of GICs cultures to treatment with TMZ, the benchmark agent for the management of GBM 2, 3, as well as to treatment with THC or a combination of THC:CBD 51. This evidence concerns the gene MDK and glioblastoma.